These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2431829)

  • 21. Influence of antigenic forms and adjuvants on protection against a lethal infection of Aujeszky's disease virus.
    Katayama S; Oda K; Ohgitani T
    Vaccine; 2000 Aug; 19(1):54-8. PubMed ID: 10924786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the bacillus of Calmette-Guérin, Propionibacter acnes and avridine as immunomodulators in antirabies vaccination of mice using the Fuenzalida-Palacios mouse brain vaccine.
    Megid J; Peraçolli MT; Curi PR; Zanetti CR; Cabrera WH; Vassao R; Ito FH
    Vaccine; 1999 May; 17(19):2446-52. PubMed ID: 10392627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application of paramunity inducers in small animal practice].
    Proksch AL; Hartmann K
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2016; 44(2):129-34. PubMed ID: 26998822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of biological response modifiers on chronic and latent murine cytomegalovirus infections.
    Okada M; Minamishima Y
    Microbiol Immunol; 1987; 31(5):435-47. PubMed ID: 2443815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mouse model to study immunity against pseudorabies virus infection: significance of CD4+ and CD8+ cells in protective immunity.
    Bianchi AT; Moonen-Leusen HW; van Milligen FJ; Savelkoul HF; Zwart RJ; Kimman TG
    Vaccine; 1998 Oct; 16(16):1550-8. PubMed ID: 9711803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of protection levels against pseudorabies virus infection of transgenic mice expressing a soluble form of porcine nectin-1/HveC and vaccinated mice.
    Ono E; Tomioka Y; Taharaguchi S; Cherel P
    Vet Microbiol; 2006 May; 114(3-4):327-30. PubMed ID: 16427216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further studies on the relative antiviral efficacies of interferons induced by poly I:C and Mengo virus.
    Campbell JB
    Can J Microbiol; 1976 May; 22(5):712-8. PubMed ID: 179687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection by polyI:polyC against infection with herpes simplex virus in mice pretreated with Corynebacterium parvum.
    Storch E; Baumgartl D; Kirchner H
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):134-42. PubMed ID: 6209572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effectiveness of immunomodulators in experimental virus infections].
    Barinskiĭ IF; Nesterchuk SL
    Vopr Virusol; 1989; 34(6):645-50. PubMed ID: 2483777
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses.
    Brockmeier SL; Lager KM; Tartaglia J; Riviere M; Paoletti E; Mengeling WL
    Vet Microbiol; 1993 Dec; 38(1-2):41-58. PubMed ID: 8128602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of hyperthermia on experimental viral infections in vitro.
    Panasiak W; Oraczewska A; Luczak M
    Adv Exp Med Biol; 1990; 267():471-5. PubMed ID: 1965095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant protection against bacterial infection in granulocytopenic mice.
    Buhles WC; Shifrine M
    J Infect Dis; 1977 Jul; 136(1):90-5. PubMed ID: 328788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A gD&gC-substituted pseudorabies virus vaccine strain provides complete clinical protection and is helpful to prevent virus shedding against challenge by a Chinese pseudorabies variant.
    Zhang C; Liu Y; Chen S; Qiao Y; Guo M; Zheng Y; Xu M; Wang Z; Hou J; Wang J
    BMC Vet Res; 2019 Jan; 15(1):2. PubMed ID: 30606159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with pseudorabies virus harboring Fc domain of IgG makes a contribution to protection of mice from lethal challenge.
    Takashima Y; Tsukamoto M; Ota H; Matsumoto Y; Hayashi Y; Otsuka H
    Vaccine; 2005 May; 23(29):3775-82. PubMed ID: 15893614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reconstitution with T lymphocytes protects nude mice from a central nervous system disorder induced by a temperature-sensitive vesicular stomatitis virus.
    Doll SC; Johnson TC
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1969-77. PubMed ID: 2841409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differing responses of hamsters to infection by vesicular stomatitis virus Indiana and New Jersey serotypes.
    Fultz PN; Holland JJ
    Virus Res; 1985 Sep; 3(2):129-40. PubMed ID: 2414943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of vesicular stomatitis virus in athymic nude mice: mutations associated with natural killer cell selection.
    Vandepol SB; Holland JJ
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():441-51. PubMed ID: 3005478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Natural killers and interferon in complicated influenza and other acute respiratory viral diseases in children].
    Ursaki LP; Madzhidov AV; Lavrukhina LA; Savitskiĭ GI
    Vopr Virusol; 1985; 30(6):680-4. PubMed ID: 2420069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative aspects of cancer immunotherapy: immunologic methods used for treatment of spontaneous cancer in animals.
    Theilen GH; Hills D
    J Am Vet Med Assoc; 1982 Nov; 181(10):1134-41. PubMed ID: 6757216
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunotherapy of breast cancer (review of foreign literature)].
    Liapis MA
    Vopr Onkol; 1983; 29(8):68-74. PubMed ID: 6351428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.